81 related articles for article (PubMed ID: 20515279)
1. Recent advances in evaluating the prognostic value of a marker.
Dalton JE; Kattan MW
Scand J Clin Lab Invest Suppl; 2010; 242():59-62. PubMed ID: 20515279
[TBL] [Abstract][Full Text] [Related]
2. Discrimination measures for survival outcomes: connection between the AUC and the predictiveness curve.
Viallon V; Latouche A
Biom J; 2011 Mar; 53(2):217-36. PubMed ID: 21308725
[TBL] [Abstract][Full Text] [Related]
3. Independent and additive prognostic ability of serum carboxy-terminal telopeptide of collagen type-I in heart failure patients: a multi-marker approach with high-negative predictive value to rule out long-term adverse events.
Tziakas DN; Chalikias GK; Stakos D; Chatzikyriakou SV; Papazoglou D; Mitrousi K; Lantzouraki A; Thomaidi A; Boudoulas H; Konstantinides S
Eur J Prev Cardiol; 2012 Feb; 19(1):62-71. PubMed ID: 20479644
[TBL] [Abstract][Full Text] [Related]
4. Plasma TNF-alpha and IL-10 level-based prognostic model predicts outcome of patients with diffuse large B-Cell lymphoma in different risk groups defined by the International Prognostic Index.
Lech-Maranda E; Bienvenu J; Broussais-Guillaumot F; Warzocha K; Michallet AS; Robak T; Coiffier B; Salles G
Arch Immunol Ther Exp (Warsz); 2010 Apr; 58(2):131-41. PubMed ID: 20191326
[TBL] [Abstract][Full Text] [Related]
5. Evaluating a new marker for risk prediction: decision analysis to the rescue.
Baker SG; Kramer BS
Discov Med; 2012 Sep; 14(76):181-8. PubMed ID: 23021372
[TBL] [Abstract][Full Text] [Related]
6. Preoperative prognostic nomogram (probability table) for renal cell carcinoma based on TNM classification.
Kanao K; Mizuno R; Kikuchi E; Miyajima A; Nakagawa K; Ohigashi T; Nakashima J; Oya M
J Urol; 2009 Feb; 181(2):480-5; discussion 485. PubMed ID: 19100568
[TBL] [Abstract][Full Text] [Related]
7. Measurement performance goals: how they can be estimated and a view to managing them.
Kallner A
Scand J Clin Lab Invest Suppl; 2010; 242():34-9. PubMed ID: 20515274
[TBL] [Abstract][Full Text] [Related]
8. Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors.
Brown JE; Cook RJ; Major P; Lipton A; Saad F; Smith M; Lee KA; Zheng M; Hei YJ; Coleman RE
J Natl Cancer Inst; 2005 Jan; 97(1):59-69. PubMed ID: 15632381
[TBL] [Abstract][Full Text] [Related]
9. Prognostic and predictive value of HER2 extracellular domain in metastatic breast cancer treated with lapatinib and paclitaxel in a randomized phase III study.
Finn RS; Gagnon R; Di Leo A; Press MF; Arbushites M; Koehler M
J Clin Oncol; 2009 Nov; 27(33):5552-8. PubMed ID: 19858400
[TBL] [Abstract][Full Text] [Related]
10. Decision making in surgical treatment of chronic low back pain: the performance of prognostic tests to select patients for lumbar spinal fusion.
Willems P
Acta Orthop Suppl; 2013 Feb; 84(349):1-35. PubMed ID: 23427903
[TBL] [Abstract][Full Text] [Related]
11. Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma.
Vasselli JR; Yang JC; Linehan WM; White DE; Rosenberg SA; Walther MM
J Urol; 2001 Jul; 166(1):68-72. PubMed ID: 11435825
[TBL] [Abstract][Full Text] [Related]
12. Predictors of ten-year event-free survival in patients with acute myocardial infarction (from the Adria, Bassano, Conegliano, and Padova Hospitals [ABC] study on myocardial infarction).
Berton G; Cordiano R; Cavuto F; Giacomini G; De Toni R; Palatini P
Am J Cardiol; 2012 Apr; 109(7):966-75. PubMed ID: 22221943
[TBL] [Abstract][Full Text] [Related]
13. Clinical validity: defining biomarker performance.
Bossuyt PM
Scand J Clin Lab Invest Suppl; 2010; 242():46-52. PubMed ID: 20515277
[TBL] [Abstract][Full Text] [Related]
14. Statistical methods for the assessment of prognostic biomarkers(part II): calibration and re-classification.
Tripepi G; Jager KJ; Dekker FW; Zoccali C
Nephrol Dial Transplant; 2010 May; 25(5):1402-5. PubMed ID: 20167948
[TBL] [Abstract][Full Text] [Related]
15. Quality of reporting of cancer prognostic marker studies: association with reported prognostic effect.
Kyzas PA; Denaxa-Kyza D; Ioannidis JP
J Natl Cancer Inst; 2007 Feb; 99(3):236-43. PubMed ID: 17284718
[TBL] [Abstract][Full Text] [Related]
16. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.
Alatengbaolide ; Lin D; Li Y; Xu H; Chen J; Wang B; Liu C; Lu P
Am J Clin Oncol; 2013 Aug; 36(4):325-30. PubMed ID: 22547011
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the prognostic significance of altered mammalian target of rapamycin pathway biomarkers in upper tract urothelial carcinoma.
Bagrodia A; Krabbe LM; Gayed BA; Kapur P; Bernstein I; Xie XJ; Wood CG; Karam JA; Weizer AZ; Raman JD; Remzi M; Rioux-Leclerq N; Haitel A; Roscigno M; Bolenz C; Bensalah K; Sagalowsky AI; Shariat SF; Lotan Y; Margulis V
Urology; 2014 Nov; 84(5):1134-40. PubMed ID: 25443916
[TBL] [Abstract][Full Text] [Related]
18. Quantifying prognosis with risk predictions.
Pace NL; Eberhart LH; Kranke PR
Eur J Anaesthesiol; 2012 Jan; 29(1):7-16. PubMed ID: 22089517
[TBL] [Abstract][Full Text] [Related]
19. High expression of the transcriptional co-activator p300 predicts poor survival in resectable non-small cell lung cancers.
Hou X; Li Y; Luo RZ; Fu JH; He JH; Zhang LJ; Yang HX
Eur J Surg Oncol; 2012 Jun; 38(6):523-30. PubMed ID: 22440742
[TBL] [Abstract][Full Text] [Related]
20. Construction and validation of a prognostic model across several studies, with an application in superficial bladder cancer.
Royston P; Parmar MK; Sylvester R
Stat Med; 2004 Mar; 23(6):907-26. PubMed ID: 15027080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
